Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced plans to present at the upcoming 35th Annual Piper Sandler Healthcare Conference in New York. Management is scheduled to present on Wednesday, November 29, 2023 at 8:10am ET. A live and archived webcast of the presentation will be available